Zenas BioPharma, Inc. (ZBIO) Operating cash flow 2023–2025
Zenas BioPharma, Inc. (ZBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$172.3MFY2025 · since FY2023: -$30.5M → -$172.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$172.3M | -44.0% |
| FY2024 | -$119.7M | -292.0% |
| FY2023 | -$30.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net incomeZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating marginZBIO Free cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →